Status
Conditions
Treatments
About
Spasticity is a common and debilitating complication in neurological conditions such as multiple sclerosis, cerebral palsy, and stroke. Stroke, a leading cause of global disability and death, occurs when blood flow to the brain is disrupted, causing neuronal damage. Approximately 80% of strokes are ischemic, with 20% being hemorrhagic. Several factors, including age, sex, vascular conditions, and lifestyle choices, increase the risk of stroke. Spasticity affects 19-28% of stroke survivors in the short term and up to 46% in the long term, severely impacting mobility and quality of life. Management typically involves pharmacological and nonpharmacological interventions, though these often have limited effectiveness and side effects. In this context, non-invasive techniques like transcutaneous stimulation with the EXOPULSE Mollii suit may offer a valuable alternative for managing spasticity and its associated symptoms.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age between 18 and 75 years.
Having a clinical diagnosis of stroke for at least three months
Being able to walk freely or with the need of support (modified Rankin score
Being a French speaker, able to understand verbal instructions, and affiliated with the national health insurance (sécurité social).
Having spasticity with a score of at least 1+ on the MAS
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
34 participants in 2 patient groups
Loading...
Central trial contact
Samar S AYACHE, MD, PhD; Moussa A CHALAH, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal